Results from the CIMBA study suggested an increased risk of breast cancer for BRCA2 mutation carriers with two copies of the ‘C’ allele at the 135G → C SNP (rs 1801320) in the 5′ untranslated region of RAD51 (Antoniou et al, 2007). This evidence concerns the gene BRCA2 and breast carcinoma.